Induction of bone marrow stromal cells into GABAergic neuronal phenotype using creatine as inducer

Restorative Neurology and Neuroscience

Volumn 30, Issue 6, 2012, Pages 511-525

  Mohammad Gharibani, Payam ^a   Tiraihi, Taki ^b   Mesbah Namin, Seyed Alireza ^b   Arabkheradmand, Jalil ^c   Kazemi, Hadi ^c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c Khatam Al Anbia Hospital   (Iran)

Author keywords

BMSCs; creatine; GABAergic like neurons; induction

Indexed keywords

BIOLOGICAL MARKER; CREATINE; FIBRONECTIN; HERMES ANTIGEN; MERCAPTOETHANOL; NESTIN; NEUROFILAMENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL THERAPY; CONTROLLED STUDY; GABAERGIC SYSTEM; HEMATOPOIETIC STEM CELL; IMMUNOREACTIVITY; IN VITRO STUDY; NEUROFILAMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GABAERGIC NEURONS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC VESICLES;

EID: 84872147176     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-2012-100155     Document Type: Article

References (72)

1. Abrajano, J.J., Qureshi, I.A., Gokhan, S., Zheng, D., Bergman, A. & Mehler, M.F. (2009). REST and CoREST modulate neuronal subtype specification, maturation and maintenance. PLoS One, 4(12), e7936.
2. Adhihetty, P.J. & Beal, M.F. (2008). Creatine and its potential therapeutic value for targeting cellular energyimpairment in neurodegenerative diseases. Neuromolecular Med, 10(4), 275-290.
3. Andres, R.H., Ducray, A.D., Huber, A.W., P'erez-Bouza, A., Krebs, S.H., Schlattner, U., Seiler, R.W., Wallimann, T. & Widmer, H.R. (2005). Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. J Neurochem, 95(1), 33-45.
4. Andres, R.H., Ducray, A.D., P'erez-Bouza, A., Schlattner, U., Huber, A.W., Krebs, S.H., Seiler, R.W.,Wallimann, T.&Widmer, H.R. (2005). Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system. Cell Transplant, 14(8), 537-550.
5. Andres, R.H., Ducray, A.D., Schlattner, U., Wallimann, T. & Widmer, H.R. (2008). Functions and effects of creatine in the central nervous system. Brain Res Bull, 76(4), 329-343.
6. Arlotta, P., Magavi, S.S. & Macklis, J.D. (2003). Induction of adult neurogenesis: Molecular manipulation of neural precursors in situ. Ann N Y Acad Sci, 991, 229-236.
7. Baraban, S.C., Southwell, D.G., Estrada, R.C., Jones, D.L., Sebe, J.Y., Alfaro-Cervello, C., Garc'ia-Verdugo, J.M., Rubenstein, J.L. & Alvarez-Buylla, A. (2009). Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci U S A, 106(36), 15472-15477.
8. Barberi, T., Klivenyi, P., Calingasan, N.Y., Lee, H., Kawamata, H., Loonam, K., Perrier, A.L., Bruses, J., Rubio, M.E., Topf, N., Tabar, V., Harrison, N.L., Beal, M.F.,Moore, M.A.&Studer, L. (2003). Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol, 21(10), 1200-1207.
9. Bender, A., Beckers, J., Schneider, I., H?olter, S.M., Haack, T., Ruthsatz, T., Vogt-Weisenhorn, D.M., Becker, L., Genius, J., Rujescu, D., Irmler, M., Mijalski, T., Mader, M., Quintanilla-Martinez, L., Fuchs, H., Gailus-Durner, V., de Angelis, M.H., Wurst, W., Schmidt, J. & Klopstock, T. (2008). Creatine improves health and survival of mice. Neurobiol Aging, 29(9), 1404-1411.
10. Benson, D.L., Mandell, J.W., Shaw, G. & Banker, G. (1996). Compartmentation of alpha-internexin and neurofilament triplet proteins in cultured hippocampal neurons. J Neurocytol, 25, 181-196.
11. Betz,W.J., Mao, F.&Bewick, G.S. (1992). Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals. J Neurosci, 12(2), 363-375.
12. Bosch, M., Pineda, J.R., Su?nol, C., Petriz, J., Cattaneo, E., Alberch, J. & Canals, J.M. (2004). Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease. Exp Neurol, 190(1), 42-58.
13. Brewer, G.J. & Wallimann, T.W. (2000). Protective effect of the energy precursor creatine against toxicity of glutamate and betaamyloid in rat hippocampal neurons. J Neurochem, 74(5), 1968-1978.
14. Buczek, M., Alvarez, J., Azhar, J., Zhou, Y., Lust, W.D., Selman, W.R. & Ratcheson, R.A. (2002). Delayed changes in regional brain energy metabolism following cerebral concussion in rats. Metab Brain Dis, 17(3), 153-167.
15. Buddhala, C., Hsu, C.C. &Wu, J.Y. (2009). A novel mechanism for GABA synthesis and packaging into Sypaptic vesicles. Neurochem Int, 55(1-3), 9-12.
16. Cochard, P. & Paulin, D. (1984). Initial expression of neurofilaments and vimentin in the central and peripheral nervous system of the mouse embryo in vivo. J Neurosci, 4(8), 2080-2094.
17. Colantonio, A., Ratcliff, G., Chase, S. & Vernich, L. (2004). Aging with traumatic brain injury: Long-term health conditions. Int J Rehabil Res, 27(3), 209-214.
18. Cousin, M. (2003). Use of FM1-43 and other derivatives to investigate neuronal function. Curr Prot Neurosci, 2.6.1-2.6.11.
19. Cox, CS Jr (2008). Cell therapies for traumatic brain injury. Neurosurg Focus, 24, E18.
20. Croft, A.P. & Przyborski, S.A. (2004). Generation of neuroprogenitor-like cells from adult mammalian bone marrow stromal cells in vitro. Stem Cells Dev, 13(4), 409-420.
21. Deldicque, L., Atherton, P., Patel, R., Theisen, D., Nielens, H., Rennie, M.J. & Francaux, M. (2008). Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. J Appl Physiol, 104(2), 371-378.
22. Dubois-Dauphin, M.L., Toni, N., Julien, S.D., Charvet, I., Sundstrom, L.E. & Stoppini, L. (2010). The long-term survival of in vitro engineered nervous tissue derived from the specific neural differentiation of mouse embryonic stem cells. Biomaterials, 31(27), 7032-7042.
23. Ducray, A., Kipfer, S., Huber, A.W., Andres, R.H., Seiler, R.W., Schlattner, U., Wallimann, T. & Widmer, H.R. (2006). Creatine and neurotrophin-4/5 promote survival of nitric oxide synthase-expressing interneurons in striatal cultures. Neurosci Lett, 395(1), 57-62.
24. Ducray, A.D., Qualls, R., Schlattner, U., Andres, R.H., Dreher, E., Seiler, R.W.,Wallimann, T. &Widmer, H.R. (2007a). Creatine promotes the GABAergic phenotype in human fetal spinal cord cultures. Brain Res, 1137(1), 50-57.
25. Ducray, A.D., Schl?appi, J.A., Qualls, R., Andres, R.H., Seiler, R.W., Schlattner, U., Wallimann, T. & Widmer, H.R. (2007b). Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord. Neurosci Res, 85(9), 1863-1875.
26. Flames, N. &Mar'in, O. (2005). Developmental mechanisms underlying the generation of cortical interneuron diversity. Neuron, 46(3), 377-381.
27. Fraichard, A., Chassande, O., Bilbaut, G., Dehay, C., Savatier, P. & Samarut, J. (1995). In vitro differentiation of embryonic stem cells into glial cells and functional neurons. J Cell Sci, 108(Pt 10), 3181-3188.
28. Garnett, M.R., Corkill, R.G., Blamire, A.M., Rajagopalan, B., Manners, D.N., Young, J.D., Styles, P. & Cadoux-Hudson, T.A. (2001). Altered cellular metabolism following traumatic brain injury: A magnetic resonance spectroscopy study. J Neurotrauma, 18(3), 231-240.
29. Gavalda, N., P'erez-Navarro, E., Gratacos, E., Comella, J.X. & Alberch, J. (2004). Differential involvement of phosphatidylinositol 3-kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons. Mol Cell Neurosci, 25(3), 460-468.
30. Gharibani, P.M., Tiraihi, T. & Arabkheradmand, J. (2010). In vitro differentiation of GABAergic cells from bone marrow stromal cells using potassium chloride as inducer. Restor Neurol Neurosci, 28(3), 367-377.
31. Goldman, S.A. (2007). Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Clin Pharmacol Ther, 82(4), 453-460.
32. Gualano, B., Ferreira, D.C., Sapienza, M.T., Seguro, A.C.&Lancha, AH Jr (2010). Effect of short-term high-dose creatine supplementation on measured GFR in a young man with a single kidney. Am J Kidney Dis, 55(3), e7-e9.
33. Henchcliffe, C., Shungu, D.C., Mao, X., Huang, C., Nirenberg, M.J., Jenkins, B.G. & Beal, M.F. (2008). Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease. Ann N Y Acad Sci, 1147, 206-220.
34. Henkel, A.W., L?ubke, J. & Betz, W.J. (1996). FM1-43 dye ultrastructural localization in and release from frog motor nerve terminals. Proc Natl Acad Sci U S A, 93(5), 1918-1923.
35. Hermann, A., Gastl, R., Liebau, S., Popa, M.O., Fiedler, J., Boehm, B.O., Maisel, M., Lerche, H., Schwarz, J., Brenner,R.&Storch, A. (2004). Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci, 117(Pt 19), 4411-4422.
36. Hermann, A., Maisel, M., Wegner, F., Liebau, S., Kim, D.W., Gerlach, M., Schwarz, J., Kim, K.S. & Storch, A. (2006). Multipotent neural stem cells from the adult tegmentum with dopaminergicpotential develop essential properties of functional neurons. Stem Cells, 24(4), 949-964.
37. Horn, M., Remkes, H., Dienesch, C., Hu, K., Ertl, G. & Neubauer, S. (1999). Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction. Cardiovasc Res, 43(1), 117-124.
38. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A. & Verfaillie, C.M. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418(6893), 41-49.
39. Joannides, A.J., Fiore-H'erich'e, C., Battersby, A.A., Athauda-Arachchi, P., Bouhon, I.A.,Williams, L.,Westmore, K., Kemp, P.J., Compston, A., Allen, N.D. & Chandran, S. (2007). A scaleable and defined system for generating neural stem cells from humanembryonic stem cells. Stem Cells, 25(3), 731-737.
40. Juravleva, E., Barbakadze, T.,Mikeladze, D.&Kekelidze, T. (2005). Creatine enhances survival of glutamate-treated neuronal/glial cells, modulates Ras/NF-kappaB signaling, and increases the generation of reactive oxygen species. J Neurosci Res, 79(1-2), 224-230.
41. Kilic, G. (2002). Exocytosis in bovine chromaffin cells: Studies with patch-clamp capacitance and FM1-43 fluorescence. Biophys J, 83, 849-857.
42. Ma, W., Fitzgerald, W., Liu, Q.Y., O'Shaughnessy, T.J., Maric, D., Lin, H.J., Alkon, D.L. & Barker, J.L. (2004). CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp Neurol, 190(2), 276-288.
43. Maisano, X., Carpentino, J., Becker, S., Lanza, R., Aaron, G., Grabel, L. & Naegele, J.R. (2009). Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy. Neurotherapeutics, 6(2), 263-277.
44. Matthews, R.T., Yang, L., Jenkins, B.G., Ferrante, R.J., Rosen, B.R., Kaddurah-Daouk, R. & Beal, M.F. (1998). Neuroprotective effects of creatine and cyclocreatine in animal models ofHuntington's disease. J Neurosci, 18(1), 156-163.
45. Mathew, S.S., Pozzo-Miller, L. & Hablitz, J.J. (2008). Kainate modulates presypaptic GABA release from two vesicle pools. J Neurosci, 28(3), 725-731.
46. McLeish, M.J. & Kenyon, G.L. (2005). Relating structure to mechanism in creatine kinase. Crit Rev Biochem Mol Biol, 40, 1-20.
47. Mochel, F., Durant, B., Meng, X., O'Callaghan, J., Yu, H., Brouillet, E., Wheeler, V.C., Humbert, S., Schiffmann, R. & Durr, A. (2012). Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem, 287(2), 1361-1370.
48. Mohammad-Gharibani, P., Tiraihi, T.&Arabkheradmand, J. (2009). In vitro transdifferentiation of bone marrow stromal cells into GABAergic-like neurons. Iran Biomed J, 13(3), 137-143.
49. Murashov, A.K., Pak, E.S., Hendricks, W.A., Owensby, J.P., Sierpinski, P.L., Tatko, L.M. & Fletcher, P.L. (2005). Directed differentiation of embryonic stem cells into dorsal interneurons. FASEB J, 19(2), 252-254.
50. Naghdi, M., Tiraihi, T., Namin, S.A. & Arabkheradmand, J. (2009). Transdifferentiation of bone marrow stromal cells into cholinergic neuronal phenotype: A potential source for cell therapy in spinal cord injury. Cytotherapy, 11(2), 137-152.
51. Nandoe Tewarie, R.S., Hurtado, A., Bartels, R.H., Grotenhuis, A. & Oudega, M. (2009). Stem cell-based therapies for spinal cord injury. J Spinal Cord Med, 32, 105-114.
52. Okano, H. (2002). Stem cell biology of the central nervous system. J Neurosci Res, 69(6), 698-707.
53. Pavan, B., Paganetto, G. & Dalpiaz, A. (2011). Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications. Drug Discov Today, 16(11-12), 520-529.
54. Pena-Altamira, E., Crochemore, C., Virgili, M. & Contestabile, A. (2005). Neurochemical correlates of differential neuroprotection by long-term dietary creatine supplementation. Brain Res, 1058(1-2), 183-188.
55. Persky, A.M., M?uller, M., Derendorf, H., Grant, M., Brazeau, G.A. &Hochhaus, G. (2003). Single-and multiple-dose pharmacokinetics of oral creatine. J Clin Pharmacol, 43(1), 29-37.
56. Rawson, E.S., Stec, M.J., Frederickson, S.J. & Miles, M.P. (2010). Low-dose creatine supplementation enhances fatigue resistance in the absence of weight gain. Nutrition, 27(4), 451-455.
57. Romand, R., Hafidi, A. & Despres, G. (1988). Immunocytochemical localization of neurofilament protein subunits in the spiral ganglion of the adult rat. Brain Res, 462, 167-173.
58. Roybon, L., Mastracci, T.L., Ribeiro, D., Sussel, L., Brundin, P. & Li, J.Y. (2010). GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2. NeuroD1, and NeuroD2. Cereb Cortex, 20(5), 1234-1244.
59. Salek, R.M., Xia, J., Innes, A., Sweatman, B.C., Adalbert, R., Randle, S., McGowan, E., Emson, P.C. & Griffin, J.L. (2010). A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int, 56(8), 937-947.
60. Shin, E., Palmer, M.J., Li, M. & Fricker, R.A. (2012). GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons In Vitro, and develop into striatal neurons In Vivo in a mouse model of Huntington's disease. Stem Cell Rev, 8(2), 513-531.
61. Tabrizi, S.J., Blamire, A.M., Manners, D.N., Rajagopalan, B., Styles, P., Schapira, A.H. & Warner, T.T. (2005). High-dose creatine therapy for Huntington disease: A 2-year clinical and MRS study. Neurology, 64(9), 1655-1656.
62. Tachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S. & Watanabe, M. (2004). Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci, 20(1), 144-160.
63. Thompson, K. (2009). Transplantation ofGABA-producing cells for seizure control in models of temporal lobe epilepsy. Neurotherapeutics, 6(2), 284-294.
64. Undamatla, J. & Szaro, B.G. (2001). Differential expression and localization of neuronal intermediate filament proteins within newly developing neurites in dissociated cultures of Xenopus laevis embryonic spinal cord. Cell Motil Cytoskeleton, 49(1), 16-32.
65. Wang, N., Guan, P., Zhang, J.P., Chang,Y.Z., Gu, L.J., Hao, F.K., Shi, Z.H.,Wang, F.Y.&Chu, L. (2011). Preventive effects of fasudil on adriamycin-induced cardiomyopathy: Possible involvement of inhibition of RhoA/ROCK pathway. Food Chem Toxicol, 49(11), 2975-2982.
66. Westmoreland, J.J., Hancock, C.R.&Condie, B.G. (2001). Neuronal development of embryonic stem cells: A model of GABAergic neuron differentiation. Biochem Biophys Res Commun, 284(3), 674-680.
67. Woodbury, D., Schwarz, E.J., Prockop, D.J. & Black, I.B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res, 61(4), 364-370.
68. Wu, Y., Zheng, Q., Guo, X., Xie, Z., Wang, Y. & Hao, J. (2005). Differentiation of bone marrow mesenchymal cells to neural cells. J Huazhong Univ Sci Technol Med Sci, 25(5), 488-490, 493.
69. Wuarin, L.&Sidell, N. (1991). Differential susceptibilities of spinal cord neurons to retinoic acid-induced survival and differentiation. Dev Biol, 144(2), 429-435.
70. Zhang, S.C.,Wernig, M., Duncan, I.D., Br?ustle, O.&Thomson, J.A. (2001). In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol, 19(12), 1129-1133.
71. Zhang, S.F., Hennessey, T., Yang, L., Starkova, N.N., Beal, M.F. & Starkov, A.A. (2011). Impaired brain creatine kinase activity in Huntington's disease. Neurodegener Dis, 8, 194-201.
72. Zhong, J., Kim, H.T., Lyu, J., Yoshikawa, K., Nakafuku, M. & Lu, W. (2011). The Wnt receptor Ryk controls specification of GABAergic neurons versus oligodendrocytes during telencephalon development. Development, 138(3), 409-419.